Analysis of natural killer cells and interleukin-15 in patients with acute fulminant hepatitis

Hepatology Research

Volumn 23, Issue 1, 2002, Pages 31-37

  Tokushige, Katsutoshi ^a   Hasegawa, Kiyoshi ^a   Yamauchi, Katsumi ^a   Hayashi, Naoaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fulminant hepatitis; IL 15; NK cell

Indexed keywords

CD16 ANTIGEN; CD57 ANTIGEN; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 15;

ACUTE HEPATITIS; ADULT; AGED; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HEPATITIS A VIRUS; HUMAN; MALE; NATURAL KILLER CELL; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

EID: 0036590411     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00154-1     Document Type: Article

References (27)

1. Dudley FJ, Fox RA, Sherlock S. Cellular immunity and hepatitis-associated Australian antigen liver disease. Lancet 1972;723-6.
2. Wands JR, Isselbacher KJ. Lymphocyte cytotoxity to autologous liver cells in chronic active hepatitis. Proc Natl Acad Sci USA 1975;72:1301-3.
3. Mondelli M, Mieli-Vergani G, Alberti A, et al. Specificity of T lymphocyte cytotoxity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 1982;129:2773-8.
4. Muto Y, Nouri-Aria K, Meager A, et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988;ii:72-4.
5. Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H. Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 1992;12:197-200.
6. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor I in acute-type fulminant hepatitis. Am J Gastroenterol 2000;95:2040-6.
7. Kamogawa Y, Yamauchi K, Obata H, Chisaka O, Matsubara K. Hepatitis B virus-DNA trasfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients. Virology 1992;191:321-6.
8. Hasegawa K, Yamauchi K, Furukawa T, Obata H. Dual color fluorescence analysis of peripheral T cell subsets in hepatitis B virus-induced liver disease. Hepatology 1988;8:1134-7.
9. Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994;1:125-33.
10. Herberman RB, Ortaldo JR. NK cells; their role in defense against disease. Science 1981;214:24-30.
11. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
12. Salvucci O, Mami-Chouaib F, Moreau JL, Chehimi J, Chonaib S. Differential regulation of interleukin-12 and interleukin-15-induced natural killer cell activation by interleukin-4. Eur J Immunol 1996;26:2736-41.
13. Orange JS, Biron CA. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996;156:4746-56.
14. Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of T cell growth factor that interacts with the b chain of interleukin-2 receptor. Science 1994;364:965-8.
15. Flamand L, Stefanescu I, Menezes J. Human herpes virus-6 enhances natural killer cell cytotoxity via IL-15. J Clin Invest 1996;97:1373-81.
16. Atedzone BN, Ahmad A, Menezes J. Enhancement of natural killer cell cytotoxity by the human herpes virus-7 via IL-15. J Immunol 1997;159:4966-72.
17. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpes virus-6 infection. Lancet 1990;335:862-3.
18. Ritz J, Scmidt RE, Michon J, Hercend T, Schlossman SF. Characterization of functional surface structures on human natural killer cells. Adv Immunol 1988;42:181-211.
19. Perussia B, Trinchieri G. Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. J Immunol 1984;132:1410-5.
20. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (H1). J Immunol 1981;127:1024-9.
21. Takahashi Y, Shimizu M. The study group of fulminant hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicenter study. J Gastroenterol Hepatol 1991;6:159-64.
22. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis. Hepatology 1996;23:389-95.
23. Okamoto H, Okada S, Sugiyama H, et al. Detection of hepatitis C virus by two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. J Gastroenterol Hepatol 1991;60:215-22.
24. Orange JS, Salazar-Mather TP, Opal SM, Biron CA. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol 1997;71:9248-58.
25. Ohnishi H, Muto Y, Maeda T, et al. Natural killer cell may inhibit liver regeneration in fulminant hepatic failure. Gastroenterologia Japonica 1993;28:40-4.
26. Vujanovic NL, Polimeno L, Azzarone A, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995;154:6324-38.
27. Tamura F, Masuhara A, Sakaida I, Fukumoto E, Nakamura T, Okita K. FK506 promotes regeneration by suppressing natural killer cell activity. J Gastroenterol Hepatol 1998;13:703-8.